Cargando…
Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome
INTRODUCTION: There is a lack of evidence about the exact deterioration of visual function associated with the age-related natural changes in the lens, particularly in intermediate (stage-2) dysfunctional lens syndrome (DLS). Standard photopic visual acuity and contrast sensitivity tests may not sho...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927489/ https://www.ncbi.nlm.nih.gov/pubmed/35107813 http://dx.doi.org/10.1007/s40123-022-00462-6 |
_version_ | 1784670454926016512 |
---|---|
author | Holgueras, Alfredo Marcos, Manuel Martínez-Plaza, Elena López-Miguel, Alberto Mansilla, Alberto Maldonado, Miguel J. |
author_facet | Holgueras, Alfredo Marcos, Manuel Martínez-Plaza, Elena López-Miguel, Alberto Mansilla, Alberto Maldonado, Miguel J. |
author_sort | Holgueras, Alfredo |
collection | PubMed |
description | INTRODUCTION: There is a lack of evidence about the exact deterioration of visual function associated with the age-related natural changes in the lens, particularly in intermediate (stage-2) dysfunctional lens syndrome (DLS). Standard photopic visual acuity and contrast sensitivity tests may not show the visual worsening in daily life activities, such as oncoming vehicle headlights at night. The purpose of this study was to analyze visual function under different conditions and glare sources in stage-2 DLS. METHODS: Forty patients over 49 years of age with initial bilateral lens opacification (Lens Opacities Classification System III [LOCS-III] scores up to 3), best-corrected visual acuity of 20/25 or better, and no ocular disease were evaluated. Binocular photopic and mesopic contrast sensitivity (CS) with/without halogen and xenon increasing glare sources were analyzed. Mesopic disability glare (MDG) was calculated as the difference between mesopic CS with/without the glare source. RESULTS: The median logarithmic CS (logCS) values were lower under mesopic conditions (1.05) than under photopic illumination (1.65; P < 0.001). Halogen and xenon glare further decreased mesopic CS (both, median logCS 0.75, P < 0.001). The mean MDG was 0.31 ± 0.10 log units for halogen glare and 0.33 ± 0.09 log units for xenon glare. The mesopic CS and MDG were not associated with any photopic test. The mesopic CS with glare but not photopic CS or mesopic CS was correlated with the LOCS-III scores. The best association was provided by MDG, which showed a pooled correlation with LOCS-III nuclear opalescence (r = 0.411, P < 0.001) and cortical scores (r = 0.226, P = 0.04). CONCLUSION: The mesopic CS under a glare source is an independent early indicator of visual impairment in stage-2 DLS patients, and appears to be substantial. Furthermore, the MDG is more sensitive than photopic and mesopic CS for evaluating patients with initial phacosclerosis. Surgeons should consider this in the decision-making process of the correct timing for lens surgery. |
format | Online Article Text |
id | pubmed-8927489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-89274892022-04-01 Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome Holgueras, Alfredo Marcos, Manuel Martínez-Plaza, Elena López-Miguel, Alberto Mansilla, Alberto Maldonado, Miguel J. Ophthalmol Ther Original Research INTRODUCTION: There is a lack of evidence about the exact deterioration of visual function associated with the age-related natural changes in the lens, particularly in intermediate (stage-2) dysfunctional lens syndrome (DLS). Standard photopic visual acuity and contrast sensitivity tests may not show the visual worsening in daily life activities, such as oncoming vehicle headlights at night. The purpose of this study was to analyze visual function under different conditions and glare sources in stage-2 DLS. METHODS: Forty patients over 49 years of age with initial bilateral lens opacification (Lens Opacities Classification System III [LOCS-III] scores up to 3), best-corrected visual acuity of 20/25 or better, and no ocular disease were evaluated. Binocular photopic and mesopic contrast sensitivity (CS) with/without halogen and xenon increasing glare sources were analyzed. Mesopic disability glare (MDG) was calculated as the difference between mesopic CS with/without the glare source. RESULTS: The median logarithmic CS (logCS) values were lower under mesopic conditions (1.05) than under photopic illumination (1.65; P < 0.001). Halogen and xenon glare further decreased mesopic CS (both, median logCS 0.75, P < 0.001). The mean MDG was 0.31 ± 0.10 log units for halogen glare and 0.33 ± 0.09 log units for xenon glare. The mesopic CS and MDG were not associated with any photopic test. The mesopic CS with glare but not photopic CS or mesopic CS was correlated with the LOCS-III scores. The best association was provided by MDG, which showed a pooled correlation with LOCS-III nuclear opalescence (r = 0.411, P < 0.001) and cortical scores (r = 0.226, P = 0.04). CONCLUSION: The mesopic CS under a glare source is an independent early indicator of visual impairment in stage-2 DLS patients, and appears to be substantial. Furthermore, the MDG is more sensitive than photopic and mesopic CS for evaluating patients with initial phacosclerosis. Surgeons should consider this in the decision-making process of the correct timing for lens surgery. Springer Healthcare 2022-02-02 2022-04 /pmc/articles/PMC8927489/ /pubmed/35107813 http://dx.doi.org/10.1007/s40123-022-00462-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Holgueras, Alfredo Marcos, Manuel Martínez-Plaza, Elena López-Miguel, Alberto Mansilla, Alberto Maldonado, Miguel J. Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title | Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title_full | Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title_fullStr | Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title_full_unstemmed | Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title_short | Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome |
title_sort | mesopic disability glare in stage-two dysfunctional lens syndrome |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927489/ https://www.ncbi.nlm.nih.gov/pubmed/35107813 http://dx.doi.org/10.1007/s40123-022-00462-6 |
work_keys_str_mv | AT holguerasalfredo mesopicdisabilityglareinstagetwodysfunctionallenssyndrome AT marcosmanuel mesopicdisabilityglareinstagetwodysfunctionallenssyndrome AT martinezplazaelena mesopicdisabilityglareinstagetwodysfunctionallenssyndrome AT lopezmiguelalberto mesopicdisabilityglareinstagetwodysfunctionallenssyndrome AT mansillaalberto mesopicdisabilityglareinstagetwodysfunctionallenssyndrome AT maldonadomiguelj mesopicdisabilityglareinstagetwodysfunctionallenssyndrome |